WASHINGTON, D.C. - Officials at the U.S. Food and Drug Administration (FDA)are asking physicians to report any cases of meningitis in patients who have received a cochlear implant after 13 people with the device have reportedly fallen ill from the bacterium.
Also, they urge healthcare workers to treat ear infections vigorously in cochlear implant patients. Two preschool-aged children with the implants have died. An additional 12 meningitis case and seven deaths of cochlear implant patients abroad are being investigated.
Experts have said that while the implants have not been found to be contaminated, invasive devices leave the body more prone to illness. Additionally, many patients who receive the auditory-aiding device have inner-ear abnormalities that may make them more prone to infection.
Meningitis can be spread by two different pathogens. The bacterial form, caused by Neisseria meningitidis, is also known as meningococcal meningitis. While this form usually begins with flu-like symptoms, it can quickly cause a headache, fever, sore throat, nausea, vomiting, a stiff neck, and patients complain about bright lights. Within a few hours, this bacterium can push a person to delirium, coma, or convulsions. It develops in the bloodstream and if the bacterium goes untreated, it can invade organs, cause a hemorrhagic rash, and gangrene. It is fatal in 15% of patients treated with antibiotics and 50% of patients who go untreated.
There are 22,000 Americans who have received cochlear implants to date.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.